National Resilience, a Well-Funded Manufacturing Startup, to Scale Back Operations

National Resilience, a well-funded manufacturing startup, to scale back operations

The startup, which has raised more than $2 billion in funding to aid young biotechs with drug production, said its “capacity expansion has outpaced industry demand.”

Manufacturing startup National Resilience to scale back operations

The biopharma company, which launched in 2020 with $800 million in venture funding, is shuttering six underutilized sites.

National Resilience, startup hoping to reinvent drug manufacturing, to ‘wind down’ many of its facilities

The company, which has raised over $2 billion, said it would “wind down” many of its facilities, while also seeking to raise an additional $250 million.

Biotech slump forces Resilience to wind down six manufacturing sites, using bankruptcy move

The venture-backed drug manufacturing company National Resilience said it will close six underutilized sites in a significant reset of its ambitions to grow into a major player in biopharmaceutical contracting. It plans to shut down ...